Cytyc Health Corp.

Axena Health CEO Eileen Maus keeps a sign in her office that reads “Sisu [noun] [Finnish]: The extraordinary and indomitable Finnish spirit to never quit and go beyond all limitations, especially in t

Cytyc needs a follow-up to its phenomenal success in the Pap smear market. It's fully focused on ductal lavage, an exciting but unproven method for evaluating breast cancer risk. The company thinks it

In many respects, Cytyc Corp. 's recently announced $553 million deal for Digene Corp. [See Deal] was a no-brainer, and expected. The companies have each developed a platform for cervical cance

Following the annus mirabilis of 1998, consolidation has landlocked the device industry, leading to a distinct ebb in the number and value of deals done. And there's little reason to believe things wi